Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M518101 in Plaque Psoriasis
NCT00884169Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing M518101 with Placebo (2 arms). Primary endpoint: Severity of plaque psoriasis. Started Jul 2009; status: completed.
02
Drugs
pefcalcitol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00884169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884169.